Professionals
Related Practices
Related Industries
A New Dawn
Insider QuarterlyJune 2009
Philip Woolfson, Guy Soussan and Gavin Coull look at the European regulatory framework developing out of the financial crisis, and how Solvency II fits in.
| 
| 
| 
| 
| 
June 2009
Beijing |
Brussels |
Century City |
Chicago |
London |
Los Angeles |
New York |
Phoenix |
Washington
- View All
- Antitrust & Competition
- Corporate, Securities & Finance
- Energy
- Environment & Natural Resources
- Chemical Regulatory
- China Chemical Regulatory
- Consumer Products/Products Liability
- EU Chemicals, REACH & CLP, Biocides & Pesticides
- EU Environmental
- Enforcement Defense
- Food & Dietary Supplements
- Food Contact Materials & Food Regulation
- NEPA Infrastructure Projects
- Nanotechnologies
- Pesticides & Antimicrobials
- Transportation of Hazardous Materials (DOT, IMO)
- US Chemical Regulatory
- US/EU Environment & Life Sciences
- Water
- ERISA, Labor & Employment
- Government Affairs & Public Policy
- Immigration
- Insurance & Reinsurance
- Asbestos, Silica & Related Bankruptcy Litigation
- China Insurance & Reinsurance
- Environmental Coverage Litigation & Counseling
- Financial Products Coverage Litigation & Counseling
- First Party Property Coverage
- Hazardous Products/Toxic Torts Coverage Litigation & Counseling
- Insurance Coverage & Bad Faith
- London & Brussels Insurance, Reinsurance & Regulatory Practice
- Reinsurance Litigation, Arbitration & Counseling
- Intellectual Property
- International Regulation & Compliance
- International Trade & Investment
- Litigation
- Appellate & Supreme Court
- Class Action
- Commercial Litigation, Insolvency & Creditors' Rights
- Complex Litigation
- Complex Litigation & Discovery Center
- Construction Mediation
- Corporate Governance
- Crisis Management
- Cross-Border Litigation
- Derivatives and Credit Default Swaps Litigation & Restructuring Team
- Distressed Real Estate Litigation & Restructuring
- E-Discovery & Document Retention
- Government Contracts
- Products Liability, Pharmaceutical & Mass Tort Litigation
- Professional Liability
- Securities Litigation & Enforcement
- Toxic Tort
- White-Collar Criminal Defense
- National and Homeland Security
- Property
- Regional
- Tax
- Corporate Tax Transactions
- Employee Benefits/ERISA/Executive Compensation
- Exempt Organizations
- IRS Controversy & Tax Litigation
- Insurance Tax
- International Tax
- International Tax Controversy and Transfer Pricing
- Legislative & Administrative, Congress & Treasury
- Partnerships/LLCs/S Corporations
- State & Local Tax
- Telecom, Internet & Media
- Transportation
- Worldwide Arbitration & Dispute Resolution
- View All
- Aerospace, Defense & Government Services
- Construction
- Electronics/Electrical
- Energy
- Exempt Organizations
- Financial Services
- Food & Agriculture
- Healthcare & Life Sciences
- Hospitality & Lodging
- Information Technology/Software
- Insurance
- Manufacturing
- Media & Entertainment
- Nanotechnologies
- Natural Resources
- Real Estate
- Retail
- Sovereign Governments and International Organizations
- Telecommunications
- Trade Associations
- Transportation
